# OnCo record shanghai-miracogen (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/shanghai-miracogen/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "shanghai-miracogen" ;
  schema:name "Shanghai Miracogen"@en ;
  schema:alternateName "Miracogen"@en, "Shanghai Miracogen Inc."@en, "美雅珂生物"@en ;
  schema:description "Shanghai Miracogen is a Chinese antibody-drug conjugate developer whose HER2 conjugate MRG002 has been tested across breast, stomach, bladder and biliary cancers and whose EGFR conjugate MRG003 targets head and neck and nasopharyngeal cancer."@en ;
  schema:url <https://onco.cc/companies/shanghai-miracogen/>, <https://www.miracogen.com/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://www.miracogen.com/> ;
  onco:tag "drug-maker" ;
  schema:addressCountry "CN" ;
  onco:drugs <https://onco.cc/drugs/mrg002/> .